CytoSorbents Comments on REMOVE Study Presentation : vimarsa

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using...

Related Keywords

Germany , United States , Efthymiosn Deliargyris , Eric Kim , Torsten Doenst , University Hospital Jena , Twitter , Material Command , European Union , Us Army , Facebook , Blood Institute , Cytosorbents Corporation , National Heart , National Institutes Of Health , Human Services , Us Department Of Health , Us Air , Corporate Communications , Head Of The Cardiothoracic Surgery Department , Cardiothoracic Surgery Department , Chief Medical Officer , Professor Doenst , Sorbents Corporation , Use Authorization , Antithrombotic Removal System , Timely Antithrombotic Removal Ticagrelor , National Institutes , Operations Command , Air Force Material Command , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Relations Contact , Investor Relations ,